Brind.

Market growth is being driven by rising chronic conditions, a trend noted in 2025 involving Baxter, Olympus Corporation, and Johnson & Johnson.

1 report, 1 independent Updated Aug 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Johnson & Johnson Olympus Corporation Baxter International

Keep exploring

The entities involved

Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
- P&G, Johnson & Johnson, and Coca-Cola are noted as dividend growth stocks, coinciding with SEC requirements for fiduciaries to prioritize interests.Mon 00:50
- Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.Sun 04:04
Olympus Corporation
Japanese company

Nothing else this week.
Baxter International
American manufacturer of healthcare goods

Nothing else this week.

Coverage

Newest first; wire copies grouped

Aug 8GlobeNewswireSigmoidoscopes Market Insights, Competitive Landscape, and Forecast 2022-2024 & 2025-2032 | North America, Healthcare Advancements and Geriatric Populations Drive Growth The sigmoidoscopes market, se